Cargando…
Design of a Novel Recombinant Multi-Epitope Vaccine against Triple-Negative Breast Cancer
BACKGROUND: TNBC is determined by the absence of ERBB2, estrogen and progesterone receptors’ expression. Cancer vaccines, as the novel immunotherapy strategies, have emerged as promising tools for treating the advanced stage of TNBC. The aim of this study was to evaluate CEA, MTDH, and MUC-1 protein...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Pasteur Institute of Iran
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987416/ https://www.ncbi.nlm.nih.gov/pubmed/35090304 http://dx.doi.org/10.52547/ibj.26.2.160 |